Recombinant Human ADP, His-tagged, S tagged
Cat.No. : | ADP-3198H |
Product Overview : | Adiponectin (ADP) |
- Specification
- Gene Information
- Related Products
Description : | This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. |
Source : | E. Coli |
Species : | Human |
Tag : | His,S-tagge |
Form : | Supplied as lyophilized form in PBS,pH7.4, containing 5% sucrose, 0.01% sarcosyl. |
Molecular Mass : | 30.3kDa |
Protein length : | 244 |
Endotoxin : | <1.0eu per 1ug (determined by the lal</1.0eu |
Purity : | >95% |
Applications : | SDS-PAGE, Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP) |
Notes : | Small volumes of ADP recombinant protein may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8 degree C for one month. Aliquot and store at -80 degree C for 12 months.Stability Test: The thermal stability is described by the loss rate of the targetprotein. The loss rate was determined by accelerated thermal degradation test,that is, incubate the protein at 37 degree C for 48h, and no obvious degradation andprecipitation were observed. (Referring from China Biological Products Standard,which was calculated by the Arrhenius equation.) The loss of this protein is lessthan 5% within the expiration date under appropriate storage condition. |
Reconstitution : | Reconstitute in sterile PBS, pH7.2-pH7.4. |
Warning : | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Gene Name : | ADP |
Official Symbol : | ADP |
Synonyms : | ADIPOQ; ADIPOQ; ACDC; ADPN; APM1; APM-1;... |
Gene ID : | 9370 |
mRNA Refseq : | NM_001177800.1 |
Protein Refseq : | NP_001171271.1 |
MIM : | 605441 |
UniProt ID : | Q15848 |
Chromosome Location : | Chromosome: 3; NC_000003.11 (186560463..186576252). Location: 3q27 |
Pathway : | AMPK signaling, organism-specific biosystem; Adipogenesis, organism-specific biosystem |
Function : | cytokine activity; hormone activity |
Products Types
◆ Assay kits | ||
Kit-0057 | ADP Colorimetric/Fluorometric Assay Kit | +Inquiry |
Kit-0056 | ADP Colorimetric Assay Kit | +Inquiry |
Kit-2430 | ADP Fluorimetric Assay Kit | +Inquiry |
Kit-0055 | ADP Assay Kit | +Inquiry |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (8)
Ask a questiones, there is evidence that ADP proteins and their receptors can be used as biomarkers for certain diseases. For example, the level of ADP released in patients with acute myocardial infarction has been shown to predict the risk of major bleeding complications during therapy with antiplatelet drugs. In addition, genetic variants associated with the P2Y12 receptor have been found to be associated with the risk of developing cardiovascular disease and stroke.
ADP proteins and their receptors have been shown to play a role in the regulation of inflammation. When tissues are damaged, platelets are activated and release a variety of pro-inflammatory molecules, including ADP. ADP can bind to P2Y1 and P2Y12 receptors on platelets and other cells, triggering the release of cytokines and chemokines that attract immune cells to the site of injury. In addition, ADP can activate immune cells directly, such as macrophages and T cells, causing them to release pro-inflammatory molecules.
There are several potential future directions for research on ADP proteins and their receptors. One area of growing interest is the role of ADP receptors in the nervous system. Studies have shown that P2Y receptors are expressed in various regions of the brain and play a role in regulating synaptic transmission, neuroinflammation, and neuroprotection. Understanding the mechanisms by which ADP receptors modulate neural function could lead to the development of novel therapies for neurological disorders, such as Alzheimer's disease and epilepsy.
Yes, there are potential side effects associated with drugs that target ADP proteins. For example, antiplatelet drugs that target the P2Y12 receptor can increase the risk of bleeding, including gastrointestinal bleeding and intracranial hemorrhage. These drugs are generally well-tolerated, however, and the benefits usually outweigh the risks.
Targeting ADP proteins, such as ADORA3, could have a range of potential benefits in the medical field. For example, ADORA3 is involved in regulating inflammation, and drugs that target this receptor could potentially be used to treat inflammatory disorders such as rheumatoid arthritis or inflammatory bowel disease. Additionally, ADORA3 is involved in the regulation of immune cells, and targeting this receptor could potentially be used to treat autoimmune diseases or to modulate the immune response in cancer patients.
Yes, there are several challenges associated with developing drugs that target ADP proteins. One challenge is that these proteins are often involved in multiple physiological processes, and disrupting their function can have unintended consequences. For example, ADP is involved in blood clotting, and drugs that target this process could increase the risk of bleeding.
Genetic variations in ADP receptors can affect drug response and disease risk in several ways. One common genetic variant in the P2Y12 receptor gene, called P2Y12-H2, has been shown to reduce the effectiveness of clopidogrel and increase the risk of cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). This variant reduces the affinity of the P2Y12 receptor for clopidogrel, so patients with this variant may require higher doses of clopidogrel or alternative antiplatelet therapies to achieve adequate platelet inhibition.
ADP plays an important role in blood clotting by activating platelets, which are small blood cells that help form blood clots to stop bleeding. When a blood vessel is damaged, platelets are activated and release ADP, which binds to specific receptors (P2Y1 and P2Y12) on the surface of other platelets, causing them to become activated as well. This initiates a cascade of events that ultimately leads to the formation of a blood clot.
Customer Reviews (2)
Write a reviewthe manufacturer has provided me with detailed documentation, including comprehensive data sheets and protocols, ensuring accuracy and reproducibility of my experiments.
I am thoroughly impressed with both the protein and the manufacturer, and I will undoubtedly continue to use their products and services in the future.
Ask a Question for All ADP Products
Required fields are marked with *
My Review for All ADP Products
Required fields are marked with *
Inquiry Basket